DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Niaspan (Niacin Extended-Release) - Current Clinical Trials


Niaspan Related Clinical Trials

Assessment of Interaction Between Vytorin and Niaspan in Healthy Subjects (P04955AM2) [Completed]

Biosynthesis of PGD2 in Vivo [Completed]

Niacin on Immune Activation : a Proof-of-concept Study [Active, not recruiting]

Comparison of TRIA-662 500 mg and Niaspan 1000 mg in Healthy Male and Female Volunteers Under Fed Conditions [Completed]

Nicotinamide Versus Sevelamer Hydrochloride on Phosphatemia Control on Chronic Hemodialysed Patients [Recruiting]

Randomized, Controlled Trial of Extended-Release Niacin (Niaspan®) to Augment Subacute Ischemic Stroke Recovery [Completed]

Effect of Niacin on Transport of HDL and Relationship to Atherogenic Lipoproteins and Lipolysis [Completed]

Study of the Effectiveness and Safety of Niaspan ® in the Treatment of Lipid Abnormalities in Latin America [Completed]

Short-term Effect of Extended-release Niacin on Endothelial Function. [Completed]

Niacin, N-3 Fatty Acids and Insulin Resistance [Completed]

Study of Niacin on Endothelial Function in HIV-infected Subjects With Low High Density Lipoprotein Cholesterol Levels [Completed]

Study of the Use of Niaspan for Treatment of Dyslipidemia in Diabetic Nephropathy [Terminated]

Study to Evaluate the EFFECTS of Acetylsalicylic Acid (ASA) on Niaspan®-Induced Flushing in Subjects With Dyslipidemia [Completed]

Nicotinamide Safety Study [Recruiting]

Metabolic Effects of an 8 Week Niaspan Treatment in Patients With Abdominal Obesity and Mixed Dyslipidemia [Completed]

The Genetics of Evoked Responses to Niacin and Endotoxemia: The GENE Study [Active, not recruiting]

Assessment Of Vascular Health After Niacin Therapy (AVANT) [Completed]

Role of Prostaglandins on Niacin-Induced Flushing [Completed]

Effect of Niacin in the Lipoprotein (a) Concentration [Completed]

Niacin/Laropiprant and Endothelial Function [Completed]

Olive Oil on Nampt and Its Relation With Postprandial Inflammation and Atherosclerosis in the Setting of Metabolic Syndrome. [Active, not recruiting]

A Study to Evaluate the Effects of Extended Release (ER) Niacin/Laropiprant, Laropiprant, ER Niacin, and Placebo on Urinary Prostanoid Metabolites in Subjects With High Cholesterol (0524A-075)(COMPLETED) [Completed]

Evaluation of the Effect of NICOtinic Acid (Niacin) on Elevated Lipoprotein(a) Levels (NICOLa Study) [Active, not recruiting]

MK0524A Clinical Efficacy Study [Completed]

Niacin and Endothelial Function in Early CKD [Completed]

Novel Pathways to Manage Inflammation and Atherosclerosis in Dialysis Patients: Role of Nicotinic Acid [Terminated]

SLIM: Combined Effects of Slo-Niacin and Atorvastatin on Lipoproteins and Inflammatory Markers in Hyperlipidemia [Completed]

Anticancer Activity of Nicotinamide on Lung Cancer [Recruiting]

ER Niacin/Laropiprant Impact on Cardiovascular Markers and Atheroprogression in HIV-infected Individuals on cART [Terminated]

The COMBINE Study: The CKD Optimal Management With BInders and NicotinamidE [Recruiting]

Niacin Skin Flush Response in Patients With Schizophrenia [Completed]

Effect of Niaspan on Cholesterol in Men [Completed]

A Study of Niaspan on Endothelium-Dependent and Endothelium-Independent Vascular Reactivity (0000-093) [Completed]

Evaluation of a Flushing ASsessment Tool (FAST) in Subjects Receiving Niacin Extended-release Plus Aspirin [Completed]

Extended Release (ER) Niacin/Laropiprant Add on Study (0524A-082) [Withdrawn]

Retrospective Study of the Effectiveness and Safety of Niacin and Steroid Eye Drops for Retinal Vein Occlusions [Active, not recruiting]

Effectiveness of Intensive Lipid Modification Medication in Preventing the Progression of Peripheral Arterial Disease (The ELIMIT Study) [Completed]

Effect of Nicotinic Acid on Adipose Tissue Inflammation in Obese Subjects [Completed]

Extended Niacin/Laropiprant in Patients With Type 2 Diabetes (0524A-069) [Completed]

A Study To See If GSK256073A Can Block Niacin-Induced Flushing In Healthy Volunteers [Completed]

Effects of Niacin On Fatty Acid Trapping [Recruiting]

Niapsan as Add -on Therapy to Antipsychotic Treatment in First Episode Psychosis [Completed]

Exercise Versus Niacin in Patients With Coronary Artery Disease (CAD) and Low High-Density Lipoproteins (HDL) [Completed]

Merck Carotid Atherosclerosis Trial (MK-0000-111)(COMPLETED) [Completed]

To Evaluate Ezetimibe/Simvastatin and Niacin (Extended Release Tablet) in Patients With Type IIa or Type IIb Hyperlipidemia (0653A-091)(COMPLETED) [Completed]

Effects of Niacin on Good Cholesterol in People With Peripheral Arterial Disease [Terminated]

Effects of Niacin Therapy on Lipoprotein Composition and Function [Recruiting]

Niacin Plus Statin to Prevent Vascular Events [Terminated]

Oxford Niaspan Study: Effects of Niaspan on Atherosclerosis and Endothelial Function [Active, not recruiting]

A Study to Evaluate Efficacy and Safety of Extended-Release Niacin (+) Laropiprant (+) Simvastatin in Participants With Primary Hypercholesterolemia or Mixed Dyslipidemia (MK-0524B-118) [Terminated]

A Prospective, Open Label Comparison of Ezetimibe, Niacin, and Colestipol as Adjunct Therapy in Lipid Reduction [Completed]

Diet, Exercise, Niacin, and Fenofibrate to Reduce Heart Disease Risk Factors in Individuals With HIV Lipodystrophy or Dyslipidemia [Completed]

Characterization of High Density Lipoprotein (HDL) in Type 2 Diabetes (T2D) After Fenofibrate or Niacin Treatment [Completed]

Efficacy and Safety of Extended-Release Niacin/ Laropiprant/Simvastatin Tablets in Participants With Hypercholesterolemia or Mixed Dyslipidemia (MK-0524B-143) [Terminated]

A Study to Evaluate the Effects of ER Niacin/Laropiprant, Laropiprant, ER Niacin, and Placebo on Urinary Prostanoid Metabolites (0524A-079)(COMPLETED) [Completed]

Efficacy and Safety of Extended Release (ER) Niacin/Laropiprant When Added to Ongoing Lipid-Modifying Therapy in Patients With High Cholesterol or Abnormal Lipid Levels (MK-0524A-133) [Terminated]

Effect of Nicotinamide in Friedreich's Ataxia [Recruiting]

A Study of Extended-release (ER) Niacin/Laropiprant in Adolescents With Heterozygous Familial Hypercholesterolemia (MK-0524A-158) [Terminated]

Nicotinamide in the Treatment of Psoriasis [Completed]

Effect of Extended-Release Niacin on Saphenous Vein Graft Atherosclerosis [Active, not recruiting]

Comparison of High-Dose Rosuvastatin Versus Low Statin Dose Plus Fenofibrate Versus Low Statin Dose Plus Niacin in the Treatment of Mixed Hyperlipidemia [Recruiting]

Lipid Efficacy of the Extended Release Niacin/Laropiprant Combination in Patients With Cardiovascular Disease [Terminated]

Niacin to Improve Blood Flow in People With Sickle Cell Disease [Completed]

Pharmacokinetic Analysis of Nicotinamide Riboside [Completed]

Effect of Nicotinic Acid on Cardiovascular Risks Indices in Polycystic Ovary Syndrome [Completed]

Obesity and Nonalcoholic Fatty Liver Disease [Completed]

Topical Myristyl Nicotinate Cream on the Skin of Healthy Volunteers [Completed]

Study of the Abuse Liability of Oxycodone HCl/Niacin in Subjects With a History of Opioid Abuse [Completed]

The Effect of Niacin Administration on Oxidative Stress in Patients With Hypercholesterolmia, as Measured by the Use of a Novel Biomarker [Not yet recruiting]

The Dose Response of Niacin ER/Lovastatin on Peak Walking Time (PWT) in Patients With Intermittent Claudication - TROPIC [Completed]

Effect of Niacin ER/Lovastatin on Peak Walking Time & Claudication Onset Time in Patients With Intermittent Claudication [Completed]

Endothelial Function, Lipoproteins, and Inflammation With Low HDL Cholesterol in HIV: ER Niacin Versus Fenofibrate [Completed]

To Study the Effectiveness and Safety of Niacin and a Topical Steroid Eye Drop to Treat Retinal Vein Occlusions [Active, not recruiting]

Study of Niacin and Rosiglitazone in Dysmetabolic Dyslipidemia [Completed]

Nicotinamide in Hemodialysis Patients With Hyperphosphatemia [Completed]

The High Density Lipoprotein and Endothelial Function, Niacin and Nitric Oxide Study (The High-Ennd Study) [Completed]

Effect of MK0524A on Flushing Caused by Niacin (0524A-056) [Completed]

The Impact of Tredaptive on Flow-Mediated Dilation in Cardiac Patients [Terminated]

Evaluation of the Safety & Efficacy of a Combination of Niacin ER & Simvastatin in Patients With Dyslipidemia (OCEANS) [Completed]

Evaluate Carotid Artery Plaque Composition by Magnetic Resonance Imaging in People Receiving Cholesterol Medication [Recruiting]

Comparative Study of the Effect of Ezetimibe Versus Extended-Release Niacin on Atherosclerosis [Terminated]

Study of Extended Release Niacin/Laropiprant on Lipids (0524A-067) [Completed]

Safety/Efficacy Study of Oxycodone HCl/Niacin to Treat Pain After Bunionectomy [Completed]

An Open-Label Study to Compare the Lipid Effects of Niacin ER and Simvastatin (NS) to Atorvastatin in Subjects With Hyperlipidemia or Mixed Dyslipidemia (SUPREME) [Completed]

Study to Test GSK256073 in Patients With Dyslipidemia [Completed]

The Effect of Vitamin B3 on Substrate Metabolism, Insulin Sensitivity, and Body Composition in Obese Men [Not yet recruiting]

Efficacy Study of Extended-Release Niacin/Lovastatin Versus Usual Care [Completed]

Colesevelam Treatment for Impaired Fasting Glucose During Niacin Therapy [Completed]

Alternative Options to Minimize Niacin-Induced Flushing [Completed]

Safety & Efficacy of a Combination Niacin ER/Simvastatin in Patients With Dyslipidemia: A Dose-Ranging Study - SEACOAST [Completed]

Effects of Nicotinic Acid Plus Simvastatin Versus Simvastatin Alone on Carotid and Femoral Intima-Media Thickness in Patients With Peripheral Artery Disease (NASCIT) [Recruiting]

MK0524A Bioequivalence Study (0524A-059) [Completed]

Niacin for Treatment of Elevated Cholesterol and Triglycerides in HIV-Infected Patients [Completed]

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017